The management board of the European Medicines Agency (EMA) agreed on June 12 to approve a new policy that would require drug companies to share certain clinical trial data with the public. It says it has added “more user-friendly amendments,” including one that will allow patients to “download, save and print the trial data for academic and noncommercial research purposes.”

…read more

Source: EMA board agrees to approve revised trial data policy


0 No comments